Tailor the program to available resources and staff, ensuring it fits the specific practice environment. Consistent patient-provider interactions enhance patient experience, though not always possible ...

Enzalutamide plus GnRH significantly improved metastasis-free survival in nmCSPC patients with high BCR risk compared to monotherapies. The study population included patients with PSA doubling time ≤ ...

"I joke that on face value, the APPs work for me, but I feel like I'm really working for them, because they basically do everything except for the surgery," says Andrew Y. Sun, MD. In this video, ...

The trial is evaluating the diagnostic performance of copper Cu 64 PSMA I&T PET/CT in men with suspected biochemical recurrence of prostate cancer following treatment with curative intent. The target ...

In this video, Kara Cossis, PA-C, MPH, discusses the role of advanced practice providers (APPs) in expanding and encouraging the use of genetic testing for prostate cancer. Cossis is a physician ...

Darolutamide plus ADT significantly improved radiological progression-free survival and overall survival in mHSPC patients compared to placebo. The ARANOTE trial demonstrated benefits in secondary ...

The TENACIO Pump's smaller design and pronounced decompression mechanism improve patient interaction with the implant. Helen L. Bernie reports no challenges in implanting the AMS 700 with TENACIO Pump ...

Targeted microwave ablation using OBT fusion shows promise in treating intermediate-risk prostate cancer with precision and safety. The VIOLETTE trial enrolled 76 patients, with 37 having completed ...

Clinicians should reassure veterans that germline testing results will not affect their service-connected benefits during pretest counseling. Veterans exposed to agents like Agent Orange or burn pits ...

Augmented reality is being used to enhance surgical training, offering immersive 3D simulations for residents. The study employs Apple Vision Pro to improve pre-operative and post-operative ...

BCG-unresponsive NMIBC is defined by persistent or recurrent high-grade tumors or carcinoma in situ after adequate BCG therapy. This condition requires alternative therapeutic strategies or radical ...

Dr. Dean Laganosky received the 2024 Trailblazer Award from LUGPA for significant contributions to urology within his first decade of practice. At 37, Dr. Laganosky has pioneered advanced urologic ...